Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   Debra Ritzwoller   and   Jessica Chubak.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.805
         
        
        
     
 
    
        
        - 
            Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study. BMC Cancer. 2019 Mar 27; 19(1):270.
            
            
                Score: 0.160
            
         
        
        - 
            Use of antidepressants after colon cancer diagnosis and risk of recurrence. Psychooncology. 2019 Apr; 28(4):750-758.
            
            
                Score: 0.159
            
         
        
        - 
            Risk of colon cancer recurrence in relation to diabetes. Cancer Causes Control. 2018 Nov; 29(11):1093-1103.
            
            
                Score: 0.155
            
         
        
        - 
            The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016 11; 27(11):1315-1323.
            
            
                Score: 0.135
            
         
        
        - 
            Test performance metrics for breast, cervical, colon and lung cancer screening: a systematic review. J Natl Cancer Inst. 2023 Feb 08.
            
            
                Score: 0.052
            
         
        
        - 
            Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590.
            
            
                Score: 0.051
            
         
        
        - 
            Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1521-1531.
            
            
                Score: 0.051
            
         
        
        - 
            Changes in use of opioid therapy after colon cancer diagnosis: a population-based study. Cancer Causes Control. 2019 Dec; 30(12):1341-1350.
            
            
                Score: 0.042